Others said members of the White House task force created to manage the pandemic response that is led by Vice President Mike Pence and includes leading infectious-disease expert Dr.
See also:Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks.
“I find it misleading to attribute political purposes to the work of science, and, in doing so, this has caused uncertainty amongst citizens, which has really made the COVID-19 pandemic have a much greater adverse impact,” Dr.
• There were more than 500,000 new cases of COVID-19 recorded worldwide on Tuesday, a record, according to Agence France-Presse.
• Peter Piot, a virologist and head of the London School of Hygiene and Tropical Medicine, said Wednesday the virus is resurging because “we relaxed too much.” Speaking at a press briefing along with European commission president, Ursula von der Leyen, whom he is advising, said the new infections coming after initial success in containing the pandemic in summer show “how fragile these gains are.”.
Officials have tested all 4.7 million residents of Kashgar, and reported 19 symptomless infections, which China does not count as official COVID-19 cases.
The number of confirmed cases of COVID-19 worldwide now stands at 44.2 million, according to data aggregated by Johns Hopkins University, and the death toll is 1.17 million.
At least 29.9 million people have recovered from COVID-19.
Brazil has the second highest death toll at 157,946 and is third by cases at 5.4 million.
India is second in cases with 7.9 million, and third in deaths at 120,010.
government signed a deal to acquire 300,000 doses of its experimental neutralizing antibody COVID-19 treatment bamlanivimab for $375 million, MarketWatch’s Jaimy Lee reported.
A Phase 2 study indicates that bamlanivimab may reduce the rate of hospitalization and viral load in some COVID-19 patients.
But the news comes just two days after the National Institutes of Health halted a clinical trial for bamlanivimab saying the therapy isn’t likely to help hospitalized COVID-19 patients recover.
There are at least three other trials of the investigational drug under way, including one testing the therapy in recently diagnosed mild to moderate COVID-19 patients that is also sponsored by the NIH.
Mild to moderate COVID-19 patients aren’t usually hospitalized.
Union, N.J.–based Bed Bath & Beyond said it is planning to buy back shares totaling up to $675 million over the next three years.
swung to a narrower-than-expected third-quarter adjusted loss, while revenue fell more than forecast.
Revenue fell 29% to $14.14 billion, just below the FactSet consensus of $14.2 billion.
Among Boeing business segments, commercial airplanes revenue dropped 56% to $3.6 billion, missing the FactSet consensus of $3.96 billion, as commercial airplanes deliveries fell 55% to 28.
Defense, space and security revenue slipped 2% to $6.85 billion but beat expectations of $6.83 billion, and global services revenue declined 21% to $3.69 billion but topped expectations of $3.64 billion.
“The global pandemic continued to add pressure to our business this quarter, and we’re aligning to this new reality by closely managing our liquidity and transforming our enterprise to be sharper, more resilient and more sustainable for the long term,” said Chief Executive Dave Calhoun.
the parent of the restaurant chains Chili’s and Maggiano’s, reported a surprise first-fiscal-quarter adjusted profit and revenue that fell less than forecast.
Same-restaurant sales fell 10.9%, with Chili’s same-restaurant sales declining 7.2% and Maggiano’s sales dropping 38.6%, as results were hurt by the COVID-19 pandemic.
The FactSet consensus for second-quarter EPS is 50 cents.
Revenue of $176.6 million was down from $217.4 million last year but also ahead of the FactSet consensus for $166 million.
“As state and local governments began to ease restrictions on dining-room service, our off-premise business at each brand still drove robust sales,” said Steve Joyce, chief executive officer of Dine Brands, referring to pandemic orders.
reported a surprise third-quarter adjusted profit and positive cash flow, as revenue fell less than forecast during the pandemic.
Revenue fell 17% to $19.42 billion, but was above the FactSet consensus of $18.73 billion.
Among GE’s business units, Power revenue rose 3% to $4.03 billion, above the FactSet consensus of $3.89 billion; Renewable Energy revenue grew 2% to $4.53 billion to top expectations of $4.48 billion; Aviation revenue tumbled 39% to $4.92 billion, just shy of expectations of $4.95 billion; and Healthcare revenue fell 7% to $4.57 billion, beating expectations of $4.14 billion
Revenue fell to $126 million from $621 million
The FactSet consensus was for a loss of 96 cents a share, and revenue of $143 million
shot upward by more that 30% on Wednesday, after the food-storage-products company reported a third-quarter profit and sales that rose well above expectations, as more consumers cook at home and store leftovers amid the pandemic
Sales rose 14% to $477.2 million, beating the FactSet consensus of $362.8 million
Tupperware Chief Executive Miguel Fernandez said the revenue growth reflects a “rapid adoption of digital tools by our sales force to combat the social restrictions surrounding COVID-19, and the increased consumer demand for our innovative and environmentally friendly products, as more consumers cook at home and are concerned with food safety and storage.”
reported third-quarter profit and revenue that rose above expectations, as all three business segments beat forecasts amid a burst in demand for delivery during the pandemic
Revenue rose 15.9% to $21.24 billion, beating the FactSet consensus of $20.21 billion
domestic package revenue rose 15.5% to $13.23 billion, above the FactSet consensus of $13.05 billion, while international package revenue grew 17% to $4.09 billion to beat expectations of $3.7 billion and supply chain and freight revenue increased 16.5% to $3.93 billion to top expectations of $3.59 billion
1 day ago
1 day ago
1 day ago
1 day ago
Get monthly updates and free resources.
CONNECT WITH US